| This week's sponsor is Premier Research. | |  | Immunotherapy: Unleashing the Body's Potential to Fight Cancer
The immune system's role in fighting cancer becomes clearer every day, and the therapeutic implications are enormous. Discover promising new approaches to immunotherapy in our new white paper.
Premier Research. It's what we do. Best. |
Featured Story | | | Friday, June 23, 2017 Bluebird Bio reported encouraging data on its revamped gene therapy for sickle cell disease and beta thalassemia this morning, but shares slipped 6% premarket on some unresolved issues. |
|
|
| This week's sponsor is Myriad RBM. | |  | |
Top Stories Friday, June 23, 2017 Aveo Pharmaceuticals’ troubled tivozanib is on the cusp of winning approval in Europe. Drug assessors in the region gave the thumbs-up to the tyrosine kinase inhibitor in kidney cancer, sending Aveo’s stock on a tear and teeing up its partner to bring the drug to market. Friday, June 23, 2017 GenSight Biologics has raised €22.5 million ($25.2 million) to prepare to bring gene therapy GS010 to market in the U.S. and Europe. The financing gives the Novartis-backed biotech enough cash to deliver data from two phase 3 trials next year and gear up for anticipated approvals on both sides of the Atlantic. Monday, June 19, 2017 How PAREXEL's New Ecosystem of Technology, Processes and Expertise is Transforming Drug Development Thursday, June 22, 2017 Just a month after FDA staff and an advisory committee gave a ringing endorsement to Pfizer's biosimilar for Amgen's blockbuster Epogen, the agency has rejected the drug for the second time. Thursday, June 22, 2017 In this week's EuroBiotech Report, Johnson & Johnson spins out Idorsia, Bavarian Nordic delays data, Woodford backs dementia fund and more. Friday, June 23, 2017 China’s FDA joined ICH as a regulatory member, Takeda wrapped up construction of new solid dosage plant in Germany, the FDA bans imports of Ipca Lab drugs. Thursday, June 22, 2017 BIO elected Alnylam CEO Maraganore as new chair, Neon tapped ex-Merrimack CFO Yasir Al-Wakeel, Biogen hired ex-Shire exec Ginger Gregory to lead human resources. Plus more hirings, firings and retirings throughout the industry. | This week's sponsor is J.P. Morgan Private Bank. | |  | How Your Assets Are Structured Can Have Long-Term Implications On Your Wealth
As a founder or executive of a healthcare business, it's crucial your assets are titled properly. J.P. Morgan Private Bank knows how to protect your assets and preserve your wealth. Download this article on asset ownership to learn more. |
| | | CSL Behring won FDA approval for its rival to Shire's hereditary angioedema franchise. Statement AbbVie and Gilead picked up regulatory nods in Europe, opening a new phase of their hepatitis C scrap. Release (PDF) Shares in Cara Therapeutics rose after the FDA bestowed breakthrough status on CR845. Statement | |
|
Resources Sponsored By: HealthCore Gain critical insights into how to design and implement pragmatic trials and generate relevant, high-level real-world evidence. Learn when to conduct PTs, design considerations, ethical regulatory issues — and more. Sponsored By: Envigo Discover the factors that contribute to differential radiation sensitivity between the Rag2 and SCID models. Presented by: Veeva Hear three innovative leaders explain how regulatory can “go digital” in their operations by leveraging the data-handling capabilities in their RIM systems. Sponsored by Envigo Performing a sophisticated surgery to create a myocardial infarction model. Join us on June 7th at 11:00 AM EDT. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. Sponsored By: Veeva Join this global webinar to learn a new approach for demonstrating medical affairs' impact with better metrics - beyond reach and frequency, enabling launch success and better engagement with strategic KOL insights, and increasing your organization's share of voice in the healthcare landscape. Sponsored By: DocuSign DocuSign’s eSignature solutions modernize healthcare and life science organizations by eliminating paper and antiquated signature processes while meeting compliance requirements and reducing costs and errors. Sponsored By: DocuSign The patients who rely on your scientific leadership are expecting more. Sponsored By: DocuSign The U.S. Department of Justice has collected upwards of $17 billion in settlements from the healthcare industry since 2009, including more than $2 billion from a single life sciences company. |
|
